INS and myeloproliferative disorder: Overactivation of the insulin pathway leads to HSC depletion as well as to uncontrolled differentiation, ultimately resulting in myeloproliferative disorder (MPD) and leukemia [121,122], while depletion of insulin growth factor-1 (IGF-1) was also shown to induce HSC differentiation [123].